Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Cover

v3.25.1
Cover
 12 Months Ended
Dec. 31, 2024
shares
Entity Addresses [Line Items]  
Document Type 20-F
Amendment Flag false
Document Registration Statement false
Document Annual Report true
Document Transition Report false
Document Shell Company Report false
Document Period End Date Dec. 31, 2024
Document Fiscal Period Focus FY
Document Fiscal Year Focus 2024
Current Fiscal Year End Date --12-31
Entity File Number 001-41231
Entity Registrant Name TC BIOPHARM (HOLDINGS) PLC
Entity Central Index Key 0001872812
Entity Incorporation, State or Country Code X0
Entity Address, Address Line One Maxim 1, 2 Parklands Way
Entity Address, Address Line Two Holytown
Entity Address, City or Town Motherwell
Entity Address, Country GB
Entity Address, Postal Zip Code ML1 4WR
Entity Well-known Seasoned Issuer No
Entity Voluntary Filers No
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Non-accelerated Filer
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Document Accounting Standard U.S. GAAP
Entity Shell Company false
Entity Common Stock, Shares Outstanding 1,991,478,441
ICFR Auditor Attestation Flag false
Document Financial Statement Error Correction [Flag] false
Auditor Name Marcum LLP
Auditor Location New York, USA
Auditor Firm ID 688
Auditor Opinion [Text Block] We have audited the accompanying consolidated balance sheets of TC BioPharm (Holdings) plc (the “Company”) as of December 31, 2024 and 2023, the related consolidated statements of operations, stockholders’ equity and cash flows for each of the three years in the period ended December 31, 2024, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2024, in conformity with accounting principles generally accepted in the United States of America.
Business Contact [Member]  
Entity Addresses [Line Items]  
Entity Address, Address Line One Maxim 1, 2 Parklands Way
Entity Address, Address Line Two Holytown
Entity Address, City or Town Motherwell
Entity Address, Country GB
Entity Address, Postal Zip Code ML1 4WR
City Area Code +44 (0)
Local Phone Number 141 433 7557
Contact Personnel Name Bryan Kobel
Contact Personnel Email Address b.kobel@tcbiopharm.com